Anlotinib followed by transarterial chemoembolization and radiofrequency ablation is a safe and effective initial treatment for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective case series study

Wang, JP; Li, XS; Wang, FJ; Shi, DG; Zhang, JR

Zhang, JR (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Oncol, 253 Gongyedadao Middle Rd, Guangzhou 510060, Peoples R China.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021; 17 (3): 619

Abstract

Background: Portal vein tumor thrombus (PVTT) remains a poor prognostic factor occurring in about 10%-40% of patients with hepatocellular carcinoma (H......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索